Although our temporal analysis confirms a clear trend toward axillary de-escalation, with ALND rates in pN0 patients declining to 24.7% by 2022, this persistence of dissection highlights a divergence from international consensus ( 23 , 24 ).
← all excerpts
Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.
2
—
—
The sentences
In patients who did not receive chemotherapy, the absolute 5-year difference in cumulative RNR was 6.19%; however, the adjusted association did not reach statistical significance.